Trial intelligence / Profile preview

Low-dose amitriptyline in uninvestigated dyspepsia

TCTR20201218006Phase 3Recruiting

Sponsor
Nantikarn Yingrattanasuk
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of amitriptyline in functional dyspepsia (FD), sponsored by Nantikarn Yingrattanasuk. Started Nov 2020; status: recruiting.

02

Drugs

amitriptyline
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on TCTR20201218006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201218006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call